INTUITIVE SURGICAL INC (1ISRG.MI) Fundamental Analysis & Valuation

BIT:1ISRG • US46120E6023

Current stock price

397.85 EUR
-0.15 (-0.04%)
Last:

This 1ISRG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 1ISRG.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1ISRG was profitable.
  • 1ISRG had a positive operating cash flow in the past year.
  • 1ISRG had positive earnings in each of the past 5 years.
  • In the past 5 years 1ISRG always reported a positive cash flow from operatings.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • With an excellent Return On Assets value of 13.96%, 1ISRG belongs to the best of the industry, outperforming 96.72% of the companies in the same industry.
  • 1ISRG has a Return On Equity of 16.02%. This is amongst the best in the industry. 1ISRG outperforms 88.52% of its industry peers.
  • The Return On Invested Capital of 1ISRG (13.95%) is better than 91.80% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1ISRG is above the industry average of 9.41%.
  • The 3 year average ROIC (12.43%) for 1ISRG is below the current ROIC(13.95%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROIC 13.95%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • 1ISRG's Profit Margin of 28.38% is amongst the best of the industry. 1ISRG outperforms 100.00% of its industry peers.
  • In the last couple of years the Profit Margin of 1ISRG has grown nicely.
  • The Operating Margin of 1ISRG (29.35%) is better than 98.36% of its industry peers.
  • 1ISRG's Operating Margin has improved in the last couple of years.
  • The Gross Margin of 1ISRG (66.00%) is better than 73.77% of its industry peers.
  • 1ISRG's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 28.38%
GM 66%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. 1ISRG.MI Health Analysis

2.1 Basic Checks

  • 1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, 1ISRG has less shares outstanding
  • Compared to 5 years ago, 1ISRG has more shares outstanding
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • 1ISRG has an Altman-Z score of 38.87. This indicates that 1ISRG is financially healthy and has little risk of bankruptcy at the moment.
  • 1ISRG's Altman-Z score of 38.87 is amongst the best of the industry. 1ISRG outperforms 98.36% of its industry peers.
  • There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 38.87
ROIC/WACC1.56
WACC8.95%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.3 Liquidity

  • 1ISRG has a Current Ratio of 4.87. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.87, 1ISRG belongs to the top of the industry, outperforming 95.08% of the companies in the same industry.
  • A Quick Ratio of 3.96 indicates that 1ISRG has no problem at all paying its short term obligations.
  • 1ISRG has a Quick ratio of 3.96. This is amongst the best in the industry. 1ISRG outperforms 96.72% of its industry peers.
Industry RankSector Rank
Current Ratio 4.87
Quick Ratio 3.96
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. 1ISRG.MI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 25.92% over the past year.
  • 1ISRG shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.42% yearly.
  • The Revenue has grown by 20.51% in the past year. This is a very strong growth!
  • Measured over the past years, 1ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 18.22% on average per year.
EPS 1Y (TTM)25.92%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%38.12%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%22.96%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.55% on average over the next years. This is quite good.
  • Based on estimates for the next years, 1ISRG will show a quite strong growth in Revenue. The Revenue will grow by 13.00% on average per year.
EPS Next Y14.43%
EPS Next 2Y14.29%
EPS Next 3Y14.44%
EPS Next 5Y13.55%
Revenue Next Year15.78%
Revenue Next 2Y14.84%
Revenue Next 3Y14.6%
Revenue Next 5Y13%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15 20

More info and screens

Find the best growth stocksShow best growing peers

2

4. 1ISRG.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1ISRG is valuated quite expensively with a Price/Earnings ratio of 48.46.
  • 1ISRG's Price/Earnings ratio is in line with the industry average.
  • 1ISRG's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.54.
  • Based on the Price/Forward Earnings ratio of 39.95, the valuation of 1ISRG can be described as expensive.
  • Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 67.21% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 21.68, 1ISRG is valued quite expensively.
Industry RankSector Rank
PE 48.46
Fwd PE 39.95
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than the industry average as 65.57% of the companies are valued more cheaply.
  • 1ISRG's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 66.45
EV/EBITDA 42.31
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
  • The excellent profitability rating of 1ISRG may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 14.44% in the coming years.
PEG (NY)3.36
PEG (5Y)2.26
EPS Next 2Y14.29%
EPS Next 3Y14.44%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1ISRG.MI Dividend Analysis

5.1 Amount

  • No dividends for 1ISRG!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1ISRG.MI Fundamentals: All Metrics, Ratios and Statistics

INTUITIVE SURGICAL INC

BIT:1ISRG (4/28/2026, 7:00:00 PM)

397.85

-0.15 (-0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength9.94
Industry Growth61.49
Earnings (Last)04-21
Earnings (Next)07-20
Inst Owners88.75%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap141.30B
Revenue(TTM)10.06B
Net Income(TTM)2.86B
Analysts79.02
Price Target516.08 (29.72%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.28%
Min EPS beat(2)9.85%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)10.81%
Min EPS beat(4)3.05%
Max EPS beat(4)18.71%
EPS beat(8)8
Avg EPS beat(8)11.52%
EPS beat(12)12
Avg EPS beat(12)8.73%
EPS beat(16)14
Avg EPS beat(16)6.39%
Revenue beat(2)2
Avg Revenue beat(2)2.19%
Min Revenue beat(2)2.17%
Max Revenue beat(2)2.22%
Revenue beat(4)4
Avg Revenue beat(4)1.83%
Min Revenue beat(4)1.09%
Max Revenue beat(4)2.22%
Revenue beat(8)5
Avg Revenue beat(8)1.43%
Revenue beat(12)7
Avg Revenue beat(12)0.96%
Revenue beat(16)9
Avg Revenue beat(16)0.46%
PT rev (1m)-3.34%
PT rev (3m)-2.8%
EPS NQ rev (1m)-0.79%
EPS NQ rev (3m)-0.7%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)2.86%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-0.07%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)0.51%
Valuation
Industry RankSector Rank
PE 48.46
Fwd PE 39.95
P/S 16.44
P/FCF 66.45
P/OCF 54.61
P/B 9.28
P/tB 9.49
EV/EBITDA 42.31
EPS(TTM)8.21
EY2.06%
EPS(NY)9.96
Fwd EY2.5%
FCF(TTM)5.99
FCFY1.5%
OCF(TTM)7.29
OCFY1.83%
SpS24.2
BVpS42.85
TBVpS41.92
PEG (NY)3.36
PEG (5Y)2.26
Graham Number88.9676 (-77.64%)
Profitability
Industry RankSector Rank
ROA 13.96%
ROE 16.02%
ROCE 16.01%
ROIC 13.95%
ROICexc 20.73%
ROICexgc 21.4%
OM 29.35%
PM (TTM) 28.38%
GM 66%
FCFM 24.75%
ROA(3y)12.67%
ROA(5y)12.15%
ROE(3y)14.56%
ROE(5y)13.99%
ROIC(3y)12.43%
ROIC(5y)12.44%
ROICexc(3y)18.4%
ROICexc(5y)18.81%
ROICexgc(3y)19.07%
ROICexgc(5y)19.65%
ROCE(3y)14.27%
ROCE(5y)14.28%
ROICexgc growth 3Y2.03%
ROICexgc growth 5Y0.92%
ROICexc growth 3Y2.86%
ROICexc growth 5Y2.05%
OM growth 3Y4.58%
OM growth 5Y3.73%
PM growth 3Y10.12%
PM growth 5Y3.12%
GM growth 3Y-0.72%
GM growth 5Y0.11%
F-Score8
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 79.72%
Cap/Sales 5.36%
Interest Coverage 250
Cash Conversion 83.46%
Profit Quality 87.21%
Current Ratio 4.87
Quick Ratio 3.96
Altman-Z 38.87
F-Score8
WACC8.95%
ROIC/WACC1.56
Cap/Depr(3y)178.7%
Cap/Depr(5y)155.64%
Cap/Sales(3y)11.2%
Cap/Sales(5y)9.67%
Profit Quality(3y)61.68%
Profit Quality(5y)71.87%
High Growth Momentum
Growth
EPS 1Y (TTM)25.92%
EPS 3Y23.94%
EPS 5Y21.42%
EPS Q2Q%38.12%
EPS Next Y14.43%
EPS Next 2Y14.29%
EPS Next 3Y14.44%
EPS Next 5Y13.55%
Revenue 1Y (TTM)20.51%
Revenue growth 3Y17.39%
Revenue growth 5Y18.22%
Sales Q2Q%22.96%
Revenue Next Year15.78%
Revenue Next 2Y14.84%
Revenue Next 3Y14.6%
Revenue Next 5Y13%
EBIT growth 1Y25.34%
EBIT growth 3Y22.76%
EBIT growth 5Y22.63%
EBIT Next Year35.45%
EBIT Next 3Y21.62%
EBIT Next 5Y17.23%
FCF growth 1Y91.03%
FCF growth 3Y37.49%
FCF growth 5Y16.85%
OCF growth 1Y25.49%
OCF growth 3Y26.68%
OCF growth 5Y15.34%

INTUITIVE SURGICAL INC / 1ISRG.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.


What is the valuation status of INTUITIVE SURGICAL INC (1ISRG.MI) stock?

ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.


What is the profitability of 1ISRG stock?

INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 9 / 10.


What is the expected EPS growth for INTUITIVE SURGICAL INC (1ISRG.MI) stock?

The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 14.43% in the next year.